|
Issue |
Title |
|
Vol 14, No 3 (2024) |
Sentinel lymph node biopsy in endometrial cancer: current status (literature review) |
Abstract
PDF (Rus)
|
P. I. Sorokin, M. V. Novozhilov, D. O. Utkin, Z. T. Abduragimova, M. A. Tishenko, A. S. Zharova, S. E. Kulikova |
|
Vol 14, No 3 (2024) |
Acute pain in oncology: specific features and treatment options. What is new? |
Abstract
PDF (Rus)
|
R. R. Sarmanaeva, G. R. Abuzarova, Yu. V. Brazhnicova |
|
Vol 14, No 3 (2024) |
Angiosarcoma of the breast (literature review and description of two clinical observations) |
Abstract
PDF (Rus)
|
R. V. Orlova, A. V. Androsova, E. E. Topuzov, N. P. Belyak, S. I. Kutukova, I. V. Avramenko, A. K. Ivanova, A. A. Varankina, A. A. Korkina, G. A. Rakhimova |
|
Vol 14, No 2 (2024) |
Total neoadjuvant therapy for locally advanced rectal cancer: a literature review |
Abstract
PDF (Rus)
|
A. V. Polynovskiy, Z. Z. Mamedli, D. V. Kuzmichev, A. A. Tryakin, O. A. Kuznetsova, S. O. Kochkina, A. A. Aniskin, A. S. Gorbunova, D. V. Aleksancev, H. R. Temirsultanova |
|
Vol 14, No 2 (2024) |
Modern view of the problem: the influence of obesity as a key component of metabolic syndrome on the development and progression of endometrial cancer |
Abstract
PDF (Rus)
|
A. Yu. Pavlov, A. G. Dzidzariya, S. Yu. Kalinchenko, P. V. Muravyeva |
|
Vol 14, No 2 (2024) |
Practical tools to facilitate the choice of adjuvant systemic therapy for resectable luminal HER2‑negative breast cancer |
Abstract
PDF (Rus)
|
S. A. Tjulandin, M. B. Stenina, M. A. Frolova |
|
Vol 14, No 2 (2024) |
Positive surgical margin after attempted radical surgery in patients with locally advanced urothelial carcinoma: literature review and case reports |
Abstract
PDF (Rus)
|
М. I. Volkova, Ya. V. Gridneva, I. S. Al-Akel, R. I. Ryabinin |
|
Vol 14, No 1 (2024) |
Existing problems of prevention and treatment of chemo-induced peripheral neuropathy: world experience and own data |
Abstract
PDF (Rus)
|
G. А. Chizh, I. V. Rykov, D. S. Orlova, S. О. Kuzin, А. В. Elmurzaev, А. В. Shishkin, V. V. Bogomolov |
|
Vol 13, No 3 (2023) |
The choice of treatment for chemorefractory colon cancer |
Abstract
PDF (Rus)
|
M. S. Cheporova, S. V. Cheporov, A. A. Tryakin |
|
Vol 13, No 3 (2023) |
De-escalation of neoadjuvant therapy as an option for patients with HER2 positive breast cancer |
Abstract
PDF (Rus)
|
T. I. Deshkina, L. V. Bolotina, P. V. Golubev, I. E. Gabuniya, M. S. Ruban, A. A. Fedenko, A. D. Kaprin |
|
Vol 13, No 3 (2023) |
Clinical significance of MET alterations in non-small cell lung cancer and currently available therapies |
Abstract
PDF (Rus)
|
S. А. Smolin, L. G. Zhukova, А. V. Smolin, D. N. Bubenko, К. S. Grechukhina |
|
Vol 13, No 3 (2023) |
Surgical treatment of recurrent intrahepatic cholangiocarcinoma (systematic review) |
Abstract
PDF (Rus)
|
N. N. Britskaya, D. V. Fisenko, M. G. Efanov |
|
Vol 13, No 4 (2023) |
Systemic therapy for metastatic pancreatic cancer |
Abstract
PDF (Rus)
|
Y. E. Chikhareva, M. Yu. Fedyanin, I. S. Bazin, I. A. Pokataev, A. A. Tryakin |
|
Vol 13, No 4 (2023) |
Current opportunities for combined treatment of gastric cancer patients with peritoneal carcinomatosis |
Abstract
PDF (Rus)
|
K. S. Titov, A. A. Kuzmenko, Z. A. Bagatelia, D. N. Grekov, V. N. Yakomaskin, T. V. Petrosyan |
|
Vol 13, No 2 (2023) |
Evolution of systemic therapy for disseminated endometrial cancer: literature review |
Abstract
PDF (Rus)
|
A. D. Darenskaya, A. A. Rumyantsev, S. L. Gutorov, A. S. Tyulyandina |
|
Vol 13, No 2 (2023) |
Organ preservation treatment of patients with atypical hyperplasia and endometrial cancer: current trends |
Abstract
PDF (Rus)
|
A. A. Petrozhitskaya, R. K. Tandelov, N. A. Zaitcev, K. Yu. Morkhov |
|
Vol 13, No 1 (2023) |
ICG fluorescence imaging for the evaluation of lymph nodes in bladder cancer |
Abstract
PDF (Rus)
|
V. N. Pavlov, M. F. Urmantsev, M. R. Bakeev |
|
Vol 13, No 2 (2023) |
Russian consensus on prevention, diagnosis and treatment of gastric cancer |
Abstract
PDF (Rus)
|
I. E. Khatkov, S. R. Abdulkhakov, S. A. Alekseenko, I. D. Amelina, D. N. Andreev, E. V. Artamonova, N. V. Bakulina, N. S. Besova, L. V. Bolotina, D. S. Bordin, O. S. Vasnev, L. Yu. Vladimirova, Z. V. Galkova, B. I. Dolgushin, L. G. Zhukova, E. O. Ignatova, R. E. Izrailov, V. A. Isakov, A. E. Kalinin, A. M. Karachun, G. G. Karmazanovskii, S. V. Kashin, V. A. Kachenko, V. A. Kim, P. V. Kononets, L. N. Kostyuchenko, T. N. Kuzmina, Yu. V. Kulezneva, S. A. Kurilovich, Yu. A. Kucheryavii, M. A. Livzan, V. K. Lyadov, I. V. Maev, O. A. Malikhova, B. M. Medvedeva, V. M. Moiseenko, S. V. Morozov, I. Yu. Nedolugko, M. F. Osipenko, E. V. Parfenchikova, V. D. Pasechnikov, S. S. Pirogov, I. A. Pokataev, S. A. Protcenko, A. B. Ryabov, N. E. Semenov, E. N. Solodinina, Yu. G. Starkov, I. S. Stilidi, D. L. Stroyakovskii, O. B. Tkachenko, A. A. Tryakin, S. А. Tjulandin, А. А. Fedenko, M. Yu. Fedyanin, S. G. Homeriki, V. M. Homyakov, V. V. Tsvirkun, V. V. Tsukanov, L. N. Shevkunov, K. V. Shishin, V. V. SHCHadrova, Yu. V. Embutnieks |
|
Vol 12, No 4 (2022) |
Psychological rehabilitation for cancer patients: from the origins to the present |
Abstract
PDF (Rus)
|
G. A. Tkachenko, A. M. Stepanova |
|
Vol 12, No 3 (2022) |
Currently available rehabilitation techniques for patients with gynecological cancer |
Abstract
PDF (Rus)
|
A. A. Petrozhitskaya, R. K. Tandelov, D. A. Bystritskaya, K. Yu. Morkhov |
|
Vol 12, No 4 (2022) |
Early and long-term neurological complications of chemotherapy in oncology (literature review) |
Abstract
PDF (Rus)
|
N. Yu. Vykhovanets, P. A. Alyoshechkin, L. A. Tomash, A. S. Shevchenko, L. A. Krasnyanskaya, A. I. Shulik |
|
Vol 12, No 3 (2022) |
Performance analysis of the quality criteria for colorectal cancer surgery |
Abstract
PDF (Rus)
|
D. А. Andreev, A. A. Zavyalov |
|
Vol 12, No 2 (2022) |
Circulating tumor DNA as a marker of minimal residual disease in non‑small cell lung cancer |
Abstract
PDF (Rus)
|
A. М. Kazakov, K. K. Laktionov, M. G. Gordiev, B. B. Akhmedov, V. A. Kuzmina |
|
Vol 12, No 2 (2022) |
Current approach in the treatment for resectable esophageal squamous‑cell carcinoma |
Abstract
PDF (Rus)
|
P. I. Akhmedov, P. V. Kononets, O. B. Abou-Haidar, I. Z. Sogov, I. A. Gladilina, O. A. Malilkhova, A. A. Tryakin |
|
Vol 12, No 1 (2022) |
Organizing the quality assessment in lung cancer care on the example of the Netherlands |
Abstract
PDF (Rus)
|
D. A. Andreev, A. A. Zavyalov |
|
Vol 11, No 3 (2021) |
Сurrent options and perspectives of systemic therapy for advanced or metastatic adrenocortical cancer |
Abstract
PDF (Rus)
|
Ya. A. Zhulikov, E. I. Kovalenko, V. Yu. Bokhian, E. V. Artamonova |
|
Vol 11, No 3 (2021) |
Unresectable hepatocellular carcinoma: prospects for drug therapy with lenvatinib |
Abstract
PDF (Rus)
|
V. V. Breder, D. T. Abdurakhmanov, V. V. Petkau, P. V. Balakhnin, M. V. Volkonsky, K. S. Grechukhina, M. A. Zafirova, I. A. Mikerov, I. A. Pokataev, A. I. Khasanova |
|
Vol 10, No 3 (2020) |
Radiation therapy for oligometastatic cancer |
Abstract
PDF (Rus)
|
N. V. Dengina, T. V. Mitin, I. V. Tsimafeyeu, S. V. Usychkin |
|
Vol 10, No 4 (2020) |
Nivolumab: 5 years from the day of international registration of immunotherapy of metastatic kidney cancer |
Abstract
PDF (Rus)
|
I. V. Tsimafeyeu |
|
Vol 10, No 2 (2020) |
The importance of circulating tumor markers in lung cancer in clinical practice |
Abstract
PDF (Rus)
|
I. V. Rykov |
|
Vol 10, No 2 (2020) |
Meta-analysis of various tki generations efficacy either alone or in combinations in EGFR mutated NSCLC |
Abstract
PDF (Rus)
|
F. V. Moiseenko, A. A. Bogdanov, N. . M. Volkov, A. S. Zhabina , M. Yu. Fedyanin |
|
Vol 10, No 2 (2020) |
Is it necessary to add anti-angiogenic therapy to chemotherapy in patients with metastatic colorectal cancer and BRAF mutation? The systematic review and meta-analysis results |
Abstract
PDF (Rus)
|
M. Yu. Fedyanin, E. M. Polyanskaya, H. H M. Elsnukaeva , A. A. Tryakin, I. А. Pokataev, Е. О. Ignatova , U. S. Sergeev , A. A. Bulanov, S. A. Tjulandin |
|
Vol 9, No 4 (2019) |
Targeted therapy for gastrointestinal and pancreatic neuroendocrine tumors |
Abstract
PDF (Rus)
|
A. Z. Isyangulova, R. Sh. Khasanov, R. F. Enikeev |
|
Vol 9, No 4 (2019) |
Microsatellite instability as a unique characteristic of tumors and a predictor of response to immune therapy |
Abstract
PDF (Rus)
|
A. A. Tryakin, M. Yu. Fedyanin, A. S. Tsukanov, Yu. A. Shelygin, I. A. Pokataev, E. O. Ignatova, G. G. Khakimova, M. A. Frolova, S. A. Tjulandin |
|
Vol 9, No 3 (2019) |
Practical aspects of modern antineoplastic therapy in locally advanced and metastatic biliary tract cancer |
Abstract
PDF (Rus)
|
V. V. Breder, S. Yu. Kruteleva, M. A. Kazantseva, K. K. Laktionov |
|
Vol 9, No 3s1 (2019) |
ИСТОЧНИКИ ПРОИСХОЖДЕНИЯ СЕРОЗНЫХ КАРЦИНОМ ЯИЧНИКА ВЫСОКОЙ СТЕПЕНИ ЗЛОКАЧЕСТВЕННОСТИ |
Abstract
PDF (Rus)
|
|
|
Vol 9, No 3s1 (2019) |
АДЪЮВАНТНАЯ ТЕРАПИЯ БОЛЬНЫХ РАКОМ ТОЛСТОЙ КИШКИ II СТАДИИ — ТРУДНОЕ РЕШЕНИЕ ДЛЯ ХИМИОТЕРАПЕВТА |
Abstract
PDF (Rus)
|
|
|
Vol 9, No 3s1 (2019) |
СТЕРЕОТАКСИЧЕСКАЯ ЛУЧЕВАЯ ТЕРАПИЯ В ФОКУСЕ СИСТЕМНЫХ ИММУНОЛОГИЧЕСКИХ ЭФФЕКТОВ |
Abstract
PDF (Rus)
|
, , |
|
Vol 9, No 3s1 (2019) |
ИНФЕКЦИИ, СВЯЗАННЫЕ С ОБРАЗОВАНИЕМ БИОПЛЕНОК |
Abstract
PDF (Rus)
|
, , , , |
|
Vol 9, No 3s1 (2019) |
ПРЕИМУЩЕСТВА И НЕДОСТАТКИ ИСПОЛЬЗОВАНИЯ ПРОКАЛЬЦИТОНИНА В КЛИНИКЕ |
Abstract
PDF (Rus)
|
, , , , |
|
Vol 9, No 2 (2019) |
The Role of the Intestinal Microbiome in the Immunotherapy of Colon Cancer |
Abstract
PDF (Rus)
|
G. G. Khakimova, A. A. Tryakin, T. N. Zabotina, A. S. Tsukanov, V. A. Aliev, S. L. Gutorov |
|
Vol 9, No 1 (2019) |
Quality of medical care for children with cancer in Ural Federal District |
Abstract
PDF (Rus)
|
M. Yu. Rykov |
|
Vol 8, No 3s1 (2018) |
Микробиом и рак: есть ли связь? Обзор литературы |
Abstract
PDF (Rus)
|
, , , |
|
Vol 8, No 3s1 (2018) |
Вопросы репродукции и BRCA-ассоциированный рак молочной железы (обзор) |
Abstract
PDF (Rus)
|
|
|
Vol 8, No 3s1 (2018) |
Обзор новых исследований, способных изменить клиническую практику при раке поджелудочной железы |
Abstract
PDF (Rus)
|
|
|
Vol 8, No 3 (2018) |
HIGH-GRADE GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASMS. MODERN CLASSIFICATION, DIAGNOSTICS AND TREATMENT |
Abstract
PDF (Rus)
|
A. A. Kolomeytseva, V. A. Gorbunova, N. F. Orel, G. S. Emelianova, A. M. Ivanov, A. S. Odintsova, A. A. Fedenko |
|
Vol 8, No 2 (2018) |
COMPARATIVE ANALYSIS OF COST OF DRUG THERAPY OF THE MOST HIGH-COST ONCOLOGICAL DISEASES IN MOSCOW |
Abstract
PDF (Rus)
|
К. I. Poliakova, M. E. Holownia-Voloskova, M. Yu. Byakhov, T. N. Ermolaeva, A. G. Fisun, V. A. Dubovtseva, E. M. Olyushina, M. V. Davydovskaya, K. A. Kokushkin |
|
Vol 8, No 1 (2018) |
Multidisciplinary approach in treatment of recurrent gastrointestinal stromal tumors: a case report and literature review |
Abstract
PDF (Rus)
|
R. V. Orlova, V. A. Kashchenko, M. D. Khanevich, A. V. Khazov, M. I. Gluzman, A. E. Zinkovskaya |
|
Vol 7, No 4 (2017) |
TARGETED DRUG BRENTUXIMAB VEDOTIN FOR TREATMENT OF RELAPSED OR REFRACTORY CD30-POSITIVE HODGKIN’S LYMPHOMA |
Abstract
PDF (Rus)
|
V. N. Stepanova, M. E. Holownia-Voloskova, D. A. Andreev, A. D. Ermolaeva, М. V. Davydovskaya, K. A. Kokushkin |
|
Vol 7, No 4 (2017) |
MOLECULAR BASIS OF MODERN TARGETED THERAPY FOR SQUAMOUS CELL CARCINOMA OF THE TONGUE AND ORAL MUCOSA WITH MONOCLONAL ANTIBODIES |
Abstract
PDF (Rus)
|
A. A. Lyanova, L. Yu. Vladimirova, E. M. Frantsiyants, D. S. Kutilin, М. A. Engibaryan |
|
Vol 7, No 4 (2017) |
CRITERIA FOR SELECTION OF PATIENTS WITH HIGH CHANCE OF COMPLETE OR OPTIMAL DEBULKING IN ADVANCED OVARIAN CANCER |
Abstract
PDF (Rus)
|
A. A. Rumyantsev, A. S. Tjulandina, I. A. Pokataev, D. Z. Kupchan, S. A. Tjulandin |
|
Vol 7, No 4 (2017) |
INDIVIDUALIZATION OF TREATMENT OF PATIENTS WITH CEREBRAL METASTASES OF MALIGNANT TUMORS. PROGNOSTIC SCALE TUNS |
Abstract
PDF (Rus)
|
V. A. Aleshin, A. H. Bekyashev, D. M. Belov, A. V. Zotov, V. B. Karahan, D. R. Naskhletashvili, E. V. Prozorenko |
|
No 3 (2017) |
Эффективность ниволумаба в лечении метастатической меланомы |
Abstract
PDF (Rus)
|
G. Y. Kharkevich, L. V. Demidov |
|
No 3 (2017) |
Fibrolamellar carcinoma as a distinct subtype of hepatocellular carcinoma: molecular genetics features, diagnostics and treatment prospects |
Abstract
PDF (Rus)
|
D. A. Shavochkina, I. F. Kustova, N. L. Lazarevich |
|
No 3 (2017) |
“Silent” ACTH-secreting carcinoma of hypophysis with extraand intracranial metastases: case report and literature review |
Abstract
PDF (Rus)
|
L. I. Astafyeva, P. L. Kalinin, N. I. Mikhaylov, Y. Y. Trunin, G. L. Kobyakov, D. R. Naskhletashvili, L. V. Shishkina, O. F. Tropinskaya |
|
No 2 (2017) |
Neoadyavant chemotherapy and postoperative irradiation in breast cancer: interrelation and prospects |
Abstract
PDF (Rus)
|
T. V. Mitin, N. V. Dengina |
|
No 2 (2017) |
The problem of current classications of the hepatocellular carcinoma. Analytical review |
Abstract
PDF (Rus)
|
D. L. Rotin, E. A. Moroz |
|
No 2 (2017) |
Metformin in breast cancer treatment |
Abstract
PDF (Rus)
|
M. A. Osipov, T. U. Semiglazova, P. V. Krivorotko, V. V. Klimenko, V. A. Kostorov, V. V. Semiglazov, E. V. Tsyrlina, I. G. Popovich, V. N. Anisimov, V. F. Semiglazov, L. M. Berstein |
|
No 2 (2017) |
Metformin as target metabolic drug in oncology |
Abstract
PDF (Rus)
|
O. P. Shatova, D. S. Kaplun, I. I. Zinkovych |
|
No 2 (2017) |
Possibilities of using alternative schemes of sunitinib therapy in patients with metastatic renal cell carcinoma |
Abstract
PDF (Rus)
|
A. V. Byakhov, A. A. Khisamov |
|
No 2 (2017) |
Immunoregulatory functions of PD-1/PD-L1 inhibitors and development of resistance to them |
Abstract
PDF (Rus)
|
M. S. Sayapina |
|
1 - 61 of 61 Items |
|